Organigram Global (OGI) Debt Ratio (2019 - 2026)
Organigram Global (OGI) reported Debt Ratio of 0.03 for Q1 2026, down 13.84% quarter-over-quarter from 0.03 in Q4 2025.
Organigram Global (OGI) Debt Ratio (2019 - 2026) Analysis & Trends
Organigram Global (OGI) has 5 years of Debt Ratio data on file, last reported at 0.03 in Q1 2026.
- Debt Ratio for Q1 2026 came in at 0.03, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 0.03 (changed N/A YoY), and the FY2025 annual result was 0.03, changed N/A from the prior year.
- Debt Ratio declined to 0.03 in Q1 2026 per OGI's latest filing, from 0.03 in the prior quarter.
- Over five years, Debt Ratio peaked at 0.05 in Q3 2025 and troughed at 0.03 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.42 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 0.60 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.01 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.30 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 0.35 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 0.24 |
| 10 | Organigram Global | 731.20 Mn | 673.26 Mn | 11.96 Mn | 0.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.03 |
| Dec 31, 2025 | 0.03 |
| Sep 30, 2025 | 0.05 |
| Feb 28, 2021 | 0.15 |
| Nov 30, 2020 | 0.24 |
| May 31, 2020 | 0.20 |
| Feb 29, 2020 | 0.17 |
| Nov 30, 2019 | 0.18 |
| Aug 31, 2019 | 0.01 |